These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36583770)

  • 1. Effects of Body Mass Index on Presentation and Outcomes of COVID-19 among Heart Transplant and Left Ventricular Assist Device Patients: A Multi-Institutional Study.
    Iyengar A; Cohen W; Han J; Helmers M; Kelly JJ; Patrick W; Moss N; Molina EJ; Sheikh FH; Houston BA; Tedford RJ; Shore S; Vorovich EE; Hsich EM; Bensitel A; Alexander KM; Chaudhry SP; Vidula H; Kilic A; Genuardi MV; Birati EY; Atluri P
    ASAIO J; 2023 Jan; 69(1):43-49. PubMed ID: 36583770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of obesity and LVAD-bridging on heart transplant candidate outcomes: a linked STS INTERMACS - OPTN/UNOS data analysis.
    Alba AC; Kirklin JK; Cantor RS; Deng L; Ross HJ; Jacobs JP; Rao V; Hanff TC; Stehlik J
    J Heart Lung Transplant; 2023 Nov; 42(11):1587-1596. PubMed ID: 37385418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity as a Risk Factor for Consideration for Left Ventricular Assist Devices.
    Mohamedali B; Yost G; Bhat G
    J Card Fail; 2015 Oct; 21(10):800-5. PubMed ID: 26093334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular assist device in patients with body mass index greater than 30 as bridge to weight loss and heart transplant candidacy.
    Yanagida R; Czer LS; Mirocha J; Rafiei M; Esmailian F; Moriguchi J; Kobashigawa JA; Trento A
    Transplant Proc; 2014 Dec; 46(10):3575-9. PubMed ID: 25498092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Obesity on Left Ventricular Assist Device Outcomes.
    Zhigalov K; Sá MPBO; Arjomandi Rad A; Vardanyan R; Goerdt L; Chrosch T; Zubarevich A; Wendt D; Pizanis N; Koch A; Kamler M; Berger R; Schmack B; Ruhparwar A; Popov AF; Weymann A
    Medicina (Kaunas); 2020 Oct; 56(11):. PubMed ID: 33113962
    [No Abstract]   [Full Text] [Related]  

  • 7. Outcomes of Obese Patients Bridged to Heart Transplantation with a Left Ventricular Assist Device.
    Okoh AK; Selevany M; Heaton J; Al-Obaidi N; Vucicevic D; Tayal R; Zucker MJ; Camacho M; Lee LY; Russo MJ
    ASAIO J; 2021 Feb; 67(2):137-143. PubMed ID: 32433308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular Assist Device Implantation and Bariatric Surgery: A Route to Transplantation in Morbidly Obese Patients with End-Stage Heart Failure.
    Jeng EI; Miller AH; Friedman J; Tapia-Ruano SA; Reilly K; Parker A; Vilaro J; Aranda JM; Klodell CT; Beaver TM; Arnaoutakis GJ; Ahmed M
    ASAIO J; 2021 Feb; 67(2):163-168. PubMed ID: 32701629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular assist devices: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(3):1-69. PubMed ID: 23074453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of infection among left ventricular assist device recipients on post-transplantation outcomes: A retrospective review.
    Lerman DT; Hamilton KW; Byrne D; Lee DF; Zeitler K; Claridge T; Gray J; Minamoto GY
    Transpl Infect Dis; 2018 Dec; 20(6):e12995. PubMed ID: 30199584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated left ventricular assist device implantation produces variable changes to patient body mass index.
    Chandratre SR; Smith NJ; Walsh RW; Kindel TL; Sundararajan SK; Joyce DL; Mohammed A
    Artif Organs; 2022 Aug; 46(8):1597-1607. PubMed ID: 35261065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes in patients with advanced heart failure and small body size undergoing continuous-flow left ventricular assist device implantation.
    Volkovicher N; Kurihara C; Critsinelis A; Kawabori M; Sugiura T; Manon M; Civitello AB; Morgan JA
    J Artif Organs; 2018 Mar; 21(1):31-38. PubMed ID: 28932915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of COVID-19 on Patients Supported with a Left Ventricular Assist Device.
    Zakrzewski J; Coyle L; Aicher T; Chickerillo K; Gallagher C; Kuper K; Sciamanna C; Chau VQ; Tatooles A
    ASAIO J; 2021 Nov; 67(11):1189-1195. PubMed ID: 34475334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Systemic and Device-Related Complications in Patients Bridged to Transplantation With Left Ventricular Assist Devices.
    Lui C; Suarez-Pierre A; Zhou X; Crawford TC; Fraser CD; Giuliano K; Hsu S; Higgins RS; Zehr KJ; Whitman GJ; Choi CW; Kilic A
    J Surg Res; 2020 Feb; 246():207-212. PubMed ID: 31605947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Renal Dysfunction Following Heart Transplantation in Patients Bridged with a Left Ventricular Assist Device.
    Tibrewala A; Khush KK; Cherikh WS; Foutz J; Stehlik J; Rich JD
    ASAIO J; 2022 May; 68(5):646-653. PubMed ID: 34419984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Destination therapy: one-year outcomes in patients with a body mass index greater than 30.
    Coyle LA; Ising MS; Gallagher C; Bhat G; Kurien S; Sobieski MA; Slaughter MS
    Artif Organs; 2010 Feb; 34(2):93-7. PubMed ID: 19995363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Durable left ventricular assist device implantation in extremely obese heart failure patients.
    Lee AY; Tecson KM; Lima B; Shaikh AF; Collier J; Still S; Baxter R; DiMaio JM; Felius J; Carey SA; Gonzalez-Stawinski GV; Nauret R; Wong M; Hall SA; Joseph SM
    Artif Organs; 2019 Mar; 43(3):234-241. PubMed ID: 30357882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and Outcomes of COVID-19 in Patients on Left Ventricular Assist Device Support.
    Birati EY; Najjar SS; Tedford RJ; Houston BA; Shore S; Vorovich E; Atluri P; Urgo K; Molina M; Chambers S; Escobar N; Hsich E; Estep JD; Alexander KM; Teuteberg JJ; Chaudhry SP; Ravichandran A; DeVore AD; Margulies KB; Hanff TC; Zimmer R; Kilic A; Wald JW; Vidula H; Martens J; Blumberg EA; Mazurek JA; Owens AT; Goldberg LR; Alvarez-Garcia J; Mancini DM; Moss N; Genuardi MV
    Circ Heart Fail; 2021 Apr; 14(4):e007957. PubMed ID: 33813838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body mass index and outcomes after left ventricular assist device placement.
    Butler J; Howser R; Portner PM; Pierson RN
    Ann Thorac Surg; 2005 Jan; 79(1):66-73. PubMed ID: 15620917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Obesity on Patients Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices.
    Clerkin KJ; Naka Y; Mancini DM; Colombo PC; Topkara VK
    JACC Heart Fail; 2016 Oct; 4(10):761-768. PubMed ID: 27614942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.